Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fisetin Intervention Study in Mild Alzheimer's Disease

NCT07279714 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT07279714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07279714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fisetin Intervention Study in Mild Alzheimer's Disease
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Phase 2
Overall status
Completed
Start date
January 27, 2026
Completion date
July 21, 2026
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, alzheimer dementia (ad), alzheimer disease, alzheimer s disease, mild cognitive disorder, neurocognitive disorder, neurocognitive disorders, mild